NCT03814603View on ClinicalTrials.gov

The Sleep Amyloid, Slow WAve Race and Ethnicity Study

CompletedOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Alzheimer Disease
Interventions
PROCEDURE

PET-MR Scan

Participants will undergo PET-MR scans at baseline and two-year follow up to examine brain amyloid deposition longitudinally.

DRUG

PiB

Subjects will receive a single dose of 555 MBq of PiB and perform a dynamic 30 min PiB PET-MR scan 60 min after injection.

Trial Locations (1)

10016

NYU Center for Brain Health, New York

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

NYU Langone Health

OTHER

NCT03814603 - The Sleep Amyloid, Slow WAve Race and Ethnicity Study | Biotech Hunter | Biotech Hunter